A Phase I, Randomized, Placebo-controlled, Single-center Study to Assess the Safety, Tolerability, and Pharmacokinetics of AZD0914 After a Single Oral Administration and to Assess the Effect of Food in Healthy Adult Volunteers

Trial Profile

A Phase I, Randomized, Placebo-controlled, Single-center Study to Assess the Safety, Tolerability, and Pharmacokinetics of AZD0914 After a Single Oral Administration and to Assess the Effect of Food in Healthy Adult Volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 10 May 2014

At a glance

  • Drugs Zoliflodacin (Primary)
  • Indications Gonorrhoea
  • Focus Adverse reactions
  • Sponsors AstraZeneca
  • Most Recent Events

    • 18 Mar 2014 The study title and treatments have been updated to exclude the multiple dose administration of AZD0914, according to a ClinicalTrials.gov record.
    • 18 Mar 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
    • 17 Jan 2014 Planned End Date changed from 1 Mar 2014 to 1 Apr 2014 as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top